However, as with any treatment, there may be minor side effects like nausea or dizziness, but these are usually temporary
Good candidates generally include seniors with: Type 2 diabetes and elevated BMI Cardiovascular disease risk factors where weight reduction would meaningfully reduce risk BMI of 30 or higher with weight-related comorbidities Adequate baseline nutritional status and no significant frailty Patients who warrant more caution include those with significant frailty, malnutrition risk, advanced chronic kidney disease, or a history of gastroparesis
A good moisturiser with ceramides and hyaluronic acid can repair if the barrier is damaged
What payers require for Mounjaro prior authorization For Mounjaro (diabetes indication), most payers require: Confirmed type 2 diabetes diagnosis with recent HbA1c level (typically above 7.0%) Documentation of current diabetes medications and their inadequacy (most plans require failure of metformin unless contraindicated) Step therapy documentation showing the patient has tried first-line agents before progressing to tirzepatide Prescriber specialty (some plans restrict initial prescribing to endocrinologists or require specialist consultation) The PA request uses the tirzepatide dosing schedule as part of the clinical rationale
The Risk of Constipation Constipation is one of the most frequently reported side effects of semaglutide
It reduces fat absorption and appetite, but must be used under veterinary supervision